These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8943696)

  • 1. Plasminogen activator inhibitor-1 overexpression in nonproliferative diabetic retinopathy.
    Grant MB; Ellis EA; Caballero S; Mames RN
    Exp Eye Res; 1996 Sep; 63(3):233-44. PubMed ID: 8943696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor (PAI)-1 overexpression in retinal microvessels of PAI-1 transgenic mice.
    Grant MB; Spoerri PE; Player DW; Bush DM; Ellis EA; Caballero S; Robison WG
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2296-302. PubMed ID: 10892876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
    Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy.
    Mathews MK; Merges C; McLeod DS; Lutty GA
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2729-41. PubMed ID: 9418725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells.
    Lockwood CJ
    Am J Obstet Gynecol; 2001 Apr; 184(5):798-804; discussion 804-5. PubMed ID: 11303186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
    Gardiner TA; Anderson HR; Stitt AW
    J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-peptide and retinal microangiopathy in diabetes.
    Chakrabarti S; Khan ZA; Cukiernik M; Zhang W; Sima AA
    Exp Diabesity Res; 2004; 5(1):91-6. PubMed ID: 15198374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
    Gendron RL; Good WV; Adams LC; Paradis H
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
    Zheng Z; Chen H; Xu X; Li C; Gu Q
    Exp Eye Res; 2007 Apr; 84(4):745-52. PubMed ID: 17303121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of vascular endothelial growth factor and basic fibroblast growth factor in early stage diabetic retinopathy and their molecular pathological mechanism].
    Song E; Dong Y; Sui DM; Zhao XZ; Wu JX
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):996-9. PubMed ID: 12899804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
    Fox SB; Taylor M; Grøndahl-Hansen J; Kakolyris S; Gatter KC; Harris AL
    J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolocalization of tissue plasminogen activator in the diabetic and nondiabetic retina and choroid.
    Lutty GA; Ikeda K; Chandler C; McLeod DS
    Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):237-45. PubMed ID: 1899653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture.
    Castellon R; Caballero S; Hamdi HK; Atilano SR; Aoki AM; Tarnuzzer RW; Kenney MC; Grant MB; Ljubimov AV
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2758-66. PubMed ID: 12147613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
    Yener S; Comlekci A; Akinci B; Demir T; Yuksel F; Ozcan MA; Bayraktar F; Yesil S
    Med Princ Pract; 2009; 18(4):266-71. PubMed ID: 19494532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
    Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
    Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
    Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy.
    Yang R; Liu H; Williams I; Chaqour B
    Ann N Y Acad Sci; 2007 Apr; 1103():196-201. PubMed ID: 17332085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.